Inventor
CHIEN KENNETH R
US22 patents
⚠️ This page may combine multiple inventors who share the name “CHIEN KENNETH R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV CALIFORNIA
9 patentsUS6451594B1Sep 17, 2002
Recombinant adenovirus for tissue specific expression in heart
UNIV CALIFORNIA23 citations89
US7745113B2Jun 29, 2010
Use of islet 1 as a marker for isolating or generating stem cells
UNIV CALIFORNIA27 citations85
US5968981AOct 19, 1999
Retinoid suppression of ventricular muscle cell hypertrophy
UNIV CALIFORNIA12 citations71
US5767155AJun 16, 1998
Retinoid suppression of ventricular muscle cell hypertrophy
UNIV CALIFORNIA7 citations71
US6306826B1Oct 23, 2001
Treatment of heart failure with growth hormone
UNIV CALIFORNIA8 citations70
US7193075B2Mar 20, 2007
Sequences upstream of the CARP gene, vectors containing them and uses thereof
UNIV CALIFORNIA2 citations60
US7399750B2Jul 15, 2008
Methods for cardiac gene transfer
UNIV CALIFORNIA4 citations57
US6060311AMay 9, 2000
Retinoid suppression of ventricular muscle cell hypertrophy
UNIV CALIFORNIA0 citations49
US6770624B2Aug 3, 2004
Treatment of heart failure with growth hormone
UNIV CALIFORNIA1 citations48
PROCELLA THERAPEUTICS AB
8 patentsUS10597637B2Mar 24, 2020
Use of jagged 1/frizzled 4 as a cell surface marker for isolating human cardiac ventricular progenitor cells
PROCELLA THERAPEUTICS AB4 citations71
US11186820B2Nov 30, 2021
Use of Neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cells
PROCELLA THERAPEUTICS AB3 citations70
US11401508B2Aug 2, 2022
Methods for isolating human cardiac ventricular progenitor cells
PROCELLA THERAPEUTICS AB2 citations67
US10508263B2Dec 17, 2019
Methods for isolating human cardiac ventricular progenitor cells
PROCELLA THERAPEUTICS AB4 citations67
US10612094B2Apr 7, 2020
Genetic markers for engraftment of human cardiac ventricular progenitor cells
PROCELLA THERAPEUTICS AB5 citations66
US10596200B2Mar 24, 2020
Use of LIFR or FGFR3 as a cell surface marker for isolating human cardiac ventricular progenitor cells
PROCELLA THERAPEUTICS AB4 citations64
US12404488B2Sep 2, 2025
Use of neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cells
PROCELLA THERAPEUTICS AB0 citations60
US11725244B2Aug 15, 2023
Genetic markers for engraftment of human cardiac ventricular progenitor cells
PROCELLA THERAPEUTICS AB1 citations56